Clinical Trial

Research on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculosis in Guangxi, China

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 6, 2024 (before its estimated January 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to find out if using mobile vans with advanced technology can help reduce tuberculosis (TB) in rural Guangxi, China. The study will also examine how practical and cost-effective this approach is. The main questions it aims to answer are: 1) Does this new screening method lower the number of TB cases among high-risk groups? and 2) Is this method practical and acceptable for communities and healthcare workers? Participants in the study will: 1) undergo TB screening with mobile vans that use artificial intelligence (AI) to read chest X-rays, 2) answer a short questionnaire about their symptoms and health history, and 3) provide sputum samples for GeneXpert testing if needed. Some communities will receive the new screening method, while others will continue with usual care. Researchers will compare TB rates in the two groups over three years to see if the new approach works better for TB control. If successful, this method could be used to improve TB control in other areas.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-20; most recent amendment 2024-12-03.
Status change: Active, Not Recruiting → Recruiting 2024-12-03
Trial Details
NCT Number NCT06702774
Lead Sponsor University of Toronto
Collaborators: Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control
Conditions Tuberculosis (TB)
Enrollment 72,000 participants
Start Date 2021-11-20
Primary Completion 2025-01-31 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-06